- The new factory will have 7,000 square meters, four times the current size factory at the Butantan Institute, the largest producer of immunobiologicals in Brazil;
- The factory is expected to be ready by the end of September.
Donations from 35 large companies and entities will finance a new vaccine factory in Brazil. The social organization in charge of the project, Comunitas, in partnership with the State of Sao Paulo’s government, via InvestSP and the Butantan Foundation, received BRL 170 million (more than $31 million).
The factory is expected to be ready by the end of September. It will produce doses of CoronaVac, the vaccine developed by the Chinese Sinovac, which has the Butantan Institute as a partner for testing and production in Brazil.
According to Folha de S.Paulo, the new factory, which is being called “Multi-Purpose Center for Vaccine Production,” will have 7,000 square meters, four times the current size factory at the Butantan Institute.
As explained by the director-president of Comunitas, Regina Esteves, to the newspaper, the building’s physical structure already exists. Still, it is being adapted, expanded, and modernized to produce the immunizer against COVID-19.
The donations came from these organizations:
- 99
- Ambev
- Americanas
- Astellas Farma Brasil
- B2W Digital
- B3
- Ball Corporation
- Banco Daycoval
- Bracell
- Bradesco
- BRF
- BTG Pactual
- CCR S.A.
- Comgás
- Cosan
- Droga Raia
- Fundação Casas Bahia
- Fundo Social/Itaú Unibanco
- iFood
- ISA CTEEP
- JBS
- Magazine Luiza
- Minerva Foods
- Novelis
- Península Participações
- Rappi
- Rede D’or
- Safra
- Banco Santander
- Sinditêxtil
- Sindusfarma
- Stone
- Vale
- Votorantim
- XP Investimentos
